Results 261 to 270 of about 93,843 (327)
Some of the next articles are maybe not open access.

Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA

Journal of Viral Hepatitis, 2019
The correlation between serum HBcrAg and HBV RNA is unclear, and correlations of intrahepatic cccDNA with HBcrAg, HBV RNA and HBsAg are rarely reported in the same cohort.
E. Chen   +6 more
semanticscholar   +1 more source

Polypeptide composition of HBsag

Archives of Virology, 1977
Purified HBsag has a complex structure comprising 8 polypeptides. Some of these polypeptides are immunogenic and induce both humoral and cell-mediated immunity in guinea pigs.
M. Teoharova   +3 more
openaire   +3 more sources

Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(−) donors

Transplant Infectious Disease, 2016
AbstractAimThe aim of this study was to determine the effects of hepatitis B surface antigen (HBsAg) positivity of the donors on graft survival and liver complications in HBsAg(+) renal transplant recipients.Patients and methodA group of 55 patients who underwent renal transplantation (RTx) in our hospital between 2001 and 2012 were included in the ...
Huseyin Kocak   +6 more
openaire   +3 more sources

DETECTION OF HBsAg IN THE PANCREAS

Acta Pathologica Japonica, 1981
Hepatitis B surface antigen (HBsAg) has been reported to be present in other organs than the liver.3,9 So far as our knowledge is concerned, however, any report of cases dealing with pancreatic diseases induced by hepatitis B virus (HBV) has not been described in the English and Japanese literature.
Isamu Sakurai   +5 more
openaire   +3 more sources

Presence of HBsAg in the Bile of Subjects with Acute HBsAg Viral Hepatitis

Pathobiology, 1975
During acute HB<sub>s</sub>Ag serum positive viral hepatitis, the surface antigen was not detectable in duodenal bile but was almost always present in gallbladder and hepatic bile when cholecystokinin was intravenously administered. The immunologic nondemonstrability of HB<sub>s</sub>Ag in duodenal bile is probably due to the ...
L. Cacciatore   +8 more
openaire   +3 more sources

Off‐therapy precipitous HBsAg decline predicts HBsAg loss after finite entecavir therapy in HBeAg‐negative patients

Journal of Viral Hepatitis, 2019
Cessation of nucleos(t)ide analogue (Nuc) therapy in HBeAg‐negative patients may increase HBsAg loss rate in patients with sustained remission (SR) and non‐retreated clinical relapsers (CR).
W. Jeng, Ming-Ling Chang, Y. Liaw
semanticscholar   +1 more source

Quantitative Determination of the HBsAg

Vox Sanguinis, 1980
Abstract. HBsAg concentrations down to 0.05 mg/ml can be measured by a quantitative immunoelectrophoresis. By a quantitative radioimmunoassay, HBsAg concentrations from 0.001 mg to 1 mg/ml can be measured.
openaire   +3 more sources

Circulating HBsAg/IgM complexes in chronic HBsAg carriers

Annales de l'Institut Pasteur / Virologie, 1983
Summary Sera of young male HBsAg carriers from Senegal were investigated for complexes between IgM and HBsAg. An enzyme-linked immunosorbent assay based on selective absorption of IgM was used. HBsAg/IgM complexes were detected in 14% of the HBsAg carriers.
J.L. Barres   +7 more
openaire   +2 more sources

Calibration of qualitative HBsAg assay results for quantitative HBsAg monitoring

Journal of Clinical Virology, 2014
Evidence is accumulating that quantitative hepatitis B surface antigen monitoring may be useful in managing patients with chronic HBV infection on certain treatment regimens. Based on these results with the Abbott Architect qualitative and quantitative HBsAg assays, it seems feasible to convert qualitative to quantitative HBsAg values for this purpose.
Julian W. Tang   +2 more
openaire   +3 more sources

HBsAg blood screening and diagnosis: performance evaluation of the ARCHITECT HBsAg qualitative and ARCHITECT HBsAg qualitative confirmatory assays

Diagnostic Microbiology and Infectious Disease, 2011
A low initial reactive rate for screening assays is important for time- and cost-effective infectious disease testing. Therefore, the new ARCHITECT HBsAg Qualitative screening assay, in conjunction with the new ARCHITECT HBsAg Qualitative Confirmatory assay, was introduced.
Christian Beckert   +8 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy